ProPhase Labs, Inc. 13D and 13G filings for Lantern Pharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:05 pm Sale |
2023-12-31 | 13G | Lantern Pharma Inc. LTRN |
ProPhase Labs Inc. PRPH |
631,195 5.800% |
-278,805 (-30.64%) |
Filing |
| 2022-11-21 4:15 pm Purchase |
2022-11-08 | 13G | Lantern Pharma Inc. LTRN |
ProPhase Labs Inc. PRPH |
910,000 8.400% |
910,000 (New Position) |
Filing |